Skip to content
2000
Volume 12, Issue 1
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

Novel oral anticoagulants (NOACs) have been developed as alternatives for vitamin K antagonists (VKAs) for the prevention of thromboembolic events in patients with a variety of medical conditions. In this review, we summarize the current data on NOACs safety and efficacy compared to VKAs and in specific patients’ groups including heart valve replacement, venous thromboembolism, advanced renal failure and the elderly.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chamc/10.2174/187152571201141201092129
2014-04-01
2025-12-21

  • From This Site

    /content/journals/chamc/10.2174/187152571201141201092129
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/chamc/10.2174/187152571201141201092129
Loading

  • Article Type:     Research Article
Keyword(s): Efficacy; novel oral anticoagulants; safety; vitamin K antagonists

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test